December 9, 2021 | Virtual Conference
Welcome
Thomas Hartung, CAAT, Johns Hopkins University, United States
Keynote Address: Advancing Alternative Methods at FDA
Donald Ingber, Wyss Institute, Harvard University, United States
MPS Hardware and Enabling Technologies (4 talks selected form submitted abstracts)
- Early and Late Calcific Aortic Valve Disease-on-a-chip | Melissa Mendoza, Binghamton University, United States
- Multi-Organ System for the Evaluation of efficacy and off-target toxicity of Anti-Cancer Therapeutics | Christopher W. McAleer, Hesperos, Inc., United States
- A machine-learned microvasculature optimizes physiological insulin secretion in a vascularized pancreas-chip | James Tronolone, Texas A&M University, United States
- Microphysiological system (MPS) platforms with high operability and pumping capability for commercialization | Kenta Shinha, Tokai University, Japan
Cell Models and Applications for MPS (4 talks selected form submitted abstracts)
- Microgravity-Induced Mitochondrial Dysfunction in Human iPSC-Based 3D Cardiac Microphysiological System | Devin Mair, Johns Hopkins University, United States
- Synovial Joint-on-a-chip System for Modeling Osteoarthritic Features and Predicting Drug Efficacy | Megan LaFollette, Zhong (Alan) Li, University of Pittsburgh, United States
- Modelling T Cell-Vasculature co-culture in a high-throughput microfluidic platform | Michelle Brouwer, MIMETAS, The Netherlands
- Engineering the neurovascular unit in vitro to improve drug delivery to the brain | Colette Bichsel, Roche, Switzerland
Panel Discussion and Q&A
Moderator | Adrian Roth, Roche, Switzerland
- Linda Griffith, Massachusetts Institute of Technology, United States
- Alysson Moutri, University of California San Diego, United States
- Peter Loskill, Tuebingen University, Germany
- Uwe Marx, TissUse, Germany
- Hiroshi Kimura, Tokai University, Japan